glp 1 age restrictions Long-term Success of GLP-1s Hinges on More Than Just a Prescription Medicare is expanding access to

People with eating disorders Profound appetite suppression in someone with a history of restrictive eating disorders could exacerbate unhealthy patterns

A color change within the same vial over time is different and concerning

Depression and neurological disorders

Cagrilintide 2.4 mg plus semaglutide 2.4 mg versus each component alone versus placebo

Research peptide users must master reconstitution calculations, proper storage, and sterile technique alongside dosing protocols

Compounded versions of semaglutide existed (and were heavily marketed through telehealth platforms), but the FDA is cracking down on compounders making GLP-1 products now that the drug shortage has ended